Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramya Krishnan

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy Oncolytics|July 6, 2019
Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy StudiesDean A Fergusson, Neil L Wesch, Garvin J Leung, et al.
Scientific Reports|May 27, 2016
First-in-class small molecule potentiators of cancer virotherapyMark H Dornan, Ramya Krishnan, Andrew M Macklin, et al.
Infectious Diseases and Therapy|September 25, 2024
Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort StudyAbi Manesh, Mithun Mohan George, Prasannakumar Palanikumar, et al.
Nature Communications|March 31, 2015
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingRozanne Arulanandam, Cory Batenchuk, Oliver Varette, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy Oncolytics|July 6, 2019
Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy StudiesDean A Fergusson, Neil L Wesch, Garvin J Leung, et al.
Scientific Reports|May 27, 2016
First-in-class small molecule potentiators of cancer virotherapyMark H Dornan, Ramya Krishnan, Andrew M Macklin, et al.
Infectious Diseases and Therapy|September 25, 2024
Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort StudyAbi Manesh, Mithun Mohan George, Prasannakumar Palanikumar, et al.
Nature Communications|March 31, 2015
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingRozanne Arulanandam, Cory Batenchuk, Oliver Varette, et al.
Pageof 4